NCT07638995

Brief Summary

The study aims to evaluate the following: 1) the incidence of new onset atrial fibrillation in patients with an atrial leadless pacemaker, 2) the need for upgrade from a standalone atrial leadless pacemaker to a dual chamber leadless pacemaker system, and 3) to compare the battery longevity of the Aveir AR at two years with the battery longevity of subjects implanted with dual chamber leadless pacemakers in the Aveir DR i2i study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
43mo left

Started May 2026

Typical duration for all trials

Geographic Reach
1 country

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
May 2026Dec 2029

Study Start

First participant enrolled

May 18, 2026

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

June 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 10, 2026

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 18, 2029

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

June 10, 2026

Status Verified

June 1, 2026

Enrollment Period

3 years

First QC Date

June 5, 2026

Last Update Submit

June 5, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of atrial fibrillation

    Incidence of atrial fibrillation in patients implanted with a single chamber (Aveir AR, Abbott) leadless pacemaker and a loop recorder.

    24 months

Secondary Outcomes (3)

  • Composite incidence of a newly prolonged PR interval

    24 months

  • Need for system upgrade from a single chamber to dual chamber

    24 months

  • Battery Longevity

    24 months

Interventions

Implantation of a loop recorder in subjects with sick sinus syndrome and normal atrioventricular conduction who are receiving an atrial leadless pacemaker as standard of care.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1. 50 patients who receive an Aveir AR device as standard of care 2. Patients willing to receive an Assert-IQ loop recorder for research purposes 3. All sexes 4. Age \> 18 years old 5. Able to provide written informed consent

You may qualify if:

  • Symptomatic sinus bradycardia
  • Sino-atrial exit block
  • Symptomatic sinus arrest with sinus pauses \> 2 sec during waking hours
  • Symptomatic sinus bradycardia \< 40 bpm for \> 1 min during waking hours
  • PR interval ≤ 0.22 sec if aged \< 70 years or PR interval ≤ 0.26 sec if aged ≥ 70 years
  • QRS width ≤ 0.12 sec
  • No prior PM implantation
  • Patients willing to receive an Assert-IQ loop recorder for research purposes

You may not qualify if:

  • Atrioventricular block
  • Bundle branch block
  • History of atrial fibrillation
  • Carotid sinus hypersensitivity
  • Planned cardiac surgery
  • Estimated life expectancy \< 1 year
  • Presence of an existing ventricular pacemaker or implantable cardioverter defibrillator
  • Known acute deep vein thrombosis of either lower extremity
  • Unable to read or write
  • Patient with Limited English Proficiency (LEP)
  • Cognitively impaired individuals
  • Pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

South Shore University Hospital

Bay Shore, New York, 11706, United States

RECRUITING

Huntington Hospital

Huntington, New York, 11743, United States

RECRUITING

North Shore University Hospital

Manhasset, New York, 11030, United States

RECRUITING

Long Island Jewish Medical Center

New Hyde Park, New York, 11040, United States

RECRUITING

Lenox Hill Hospital

New York, New York, 10075, United States

RECRUITING

Staten Island University Hospital

Staten Island, New York, 10305, United States

RECRUITING

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • James Gabriels, MD

    Northwell Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Salome Elia Reddy

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2026

First Posted

June 10, 2026

Study Start

May 18, 2026

Primary Completion (Estimated)

May 18, 2029

Study Completion (Estimated)

December 31, 2029

Last Updated

June 10, 2026

Record last verified: 2026-06

Locations